Skip to main content
. 2015 Mar 15;8(3):3855–3861.

Figure 3.

Figure 3

Effect of zoledronic acid on incidence of nonvertebral fractures.Pooled estimate for the risk of nonvertebral fractures showing a reduction in vertebral fractures with zoledronic acid.Heterogeneity chi-squared = 0.03 (d.f. = 1) P = 0.864; Test of RR = 1: z = 4.31 P = 0.000.